Edition:
United Kingdom

People: Retrophin Inc (RTRX.OQ)

RTRX.OQ on NASDAQ Stock Exchange Global Market

25.82USD
21 Nov 2018
Change (% chg)

$0.78 (+3.12%)
Prev Close
$25.04
Open
$25.27
Day's High
$25.97
Day's Low
$25.27
Volume
103,648
Avg. Vol
139,673
52-wk High
$32.99
52-wk Low
$20.16

Clague, Laura 

Ms. Laura M. Clague, CPA is the Senior Vice President and Chief Financial Officer of the Company. Ms. Clague has served as the Senior Vice President and Chief Financial Officer of the Company since November 17, 2014. Ms. Clague previously served as the Chief Financial Officer of the San Diego and Ohio operations of Amylin Pharmaceuticals, Inc., a wholly owned subsidiary of Bristol-Myers Squibb. Prior to the acquisition by Bristol-Myers Squibb in 2012, Ms. Clague was the Vice President, Corporate Controller and Chief Accounting Officer of Amylin for 10 years, and during this time also served as the Chief Financial Officer of the Amylin/Lilly Collaboration. From 1988 to 1999, Ms. Clague was the director of finance and accounting operations for Sony Electronics, Inc. From 1985 to 1988, Ms. Clague served as internal audit supervisor at Cubic Corporation. From 1982 to 1985, Ms. Clague held various audit positions at KPMG. Ms. Clague also serves on the Board of Directors of LRAD Corporation where she chairs the Audit Committee and is on the Compensation Committee. Ms. Clague is a certified public accountant in the State of California, and has a B.S. in Business Administration from Menlo College.

Basic Compensation

Total Annual Compensation, USD 382,467
Restricted Stock Award, USD 304,913
Long-Term Incentive Plans, USD --
All Other, USD 809,258
Fiscal Year Total, USD 1,496,640

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gary Lyons

244,845

Stephen Aselage

3,428,320

Laura Clague

1,496,640

Neil McFarlane

2,186,980

Elizabeth Reed

1,582,450

William Rote

1,853,640
As Of  31 Dec 2017